InvestorsObserver is giving Outlook Therapeutics Inc (OTLK) an Analyst Rating Rank of 5, meaning OTLK is ranked higher by analysts than 5% of stocks. The average price target for OTLK is $3 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating OTLK a Hold today. Find out what this means to you and get the rest of the rankings on OTLK!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Outlook Therapeutics Inc Stock Today?
Outlook Therapeutics Inc (OTLK) stock is trading at $0.51 as of 12:35 PM on Tuesday, Oct 24, a rise of $0.05, or 10.15% from the previous closing price of $0.46. The stock has traded between $0.45 and $0.51 so far today. Volume today is below average. So far 7,099,025 shares have traded compared to average volume of 9,990,825 shares.
Click Here to get the full Stock Report for Outlook Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter